According to the new market research report "Amniocentesis Needle Market by Type
(Smaller Than 100 mm, 100 - 150 mm, Larger Than 150 mm), Procedure
(Amniocentesis, Amnioreduction, Fetal Blood Transfusion, Amnioinfusion), End
User (Hospitals, Diagnostic Centers, Clinics) - Global Forecast to 2022", published
by MarketsandMarkets™, analyzes and studies the major market
drivers, restraints/challenges, and opportunities in North America, Europe,
Asia-Pacific, and the Rest of the world (RoW).
Don’t miss out on business opportunities in Amniocentesis Needle Market.
Speak to our analyst and gain crucial industry insights that will help your business grow: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=18541768
The amniocentesis needles market is expected to reach
USD 172.8 million by 2022 from USD 146.4 million in 2016 at a CAGR of 2.8%.
The base year for this study is 2016 and the forecast
period is 2017–2022. 100–150 mm needles are the most commonly used amniocentesis
needles and are expected to account for the largest share of the global market
in 2017. The large share of this segment can be attributed to the fact that
these needles are suitable for most patients on account of their optimal
length.
Use
of amniocentesis needles in amniocentesis procedures drives the global 100–150
mm needles market
This type of needle is suitable for use in females with a normal body-mass index (BMI) of 18.50–24.99 kg/m2. There is an increase in the proportion of women who are overweight, this proportion will still be lesser than the proportion of women with normal BMI. This is one of the major factors responsible for the large share of 100–150 mm needles in the amniocentesis needles market. Amniocentesis procedure is the most commonly recommended invasive prenatal diagnostic test to detect chromosomal disorders, infections, or birth defects. In spite of a small proportion of risks associated with this procedure, amniocentesis is carried out to diagnose the abnormalities in the developing fetus. These are the major factors responsible for the large share of this procedure segment in the amniocentesis needles market.
This type of needle is suitable for use in females with a normal body-mass index (BMI) of 18.50–24.99 kg/m2. There is an increase in the proportion of women who are overweight, this proportion will still be lesser than the proportion of women with normal BMI. This is one of the major factors responsible for the large share of 100–150 mm needles in the amniocentesis needles market. Amniocentesis procedure is the most commonly recommended invasive prenatal diagnostic test to detect chromosomal disorders, infections, or birth defects. In spite of a small proportion of risks associated with this procedure, amniocentesis is carried out to diagnose the abnormalities in the developing fetus. These are the major factors responsible for the large share of this procedure segment in the amniocentesis needles market.
Browse and in-depth TOC on "Amniocentesis Needle Market"
74 – Tables
34 - Figures
132 - Pages
View more detailed TOC @ https://www.marketsandmarkets.com/Market-Reports/amniocentesis-needle-market-18541768.html
The following are the major objectives of the study:
74 – Tables
34 - Figures
132 - Pages
View more detailed TOC @ https://www.marketsandmarkets.com/Market-Reports/amniocentesis-needle-market-18541768.html
The following are the major objectives of the study:
· To define, describe,
segment, and forecast the amniocentesis needles market on the basis of type,
procedure, end user, and region
·
To forecast revenue
of the market segments with respect to four main regional segments, namely,
North America, Europe, Asia, and the Rest of the World (RoW)
·
To identify the
micromarkets with respect to drivers, restraints, industry-specific challenges,
opportunities, and trends affecting the growth of the market
·
To strategically
analyze market segments and subsegments with respect to individual growth
trends, prospects, and contributions to the overall market
·
To analyze
opportunities in the market for stakeholders and provide details of the
competitive landscape for market leaders
·
To profile the key
players and comprehensively analyze their market position and core competencies
in terms of market developments and growth strategies
·
To track and analyze
competitive developments such as partnerships, agreements, collaborations, and
joint ventures; mergers and acquisitions; product launches; and research and
development activities in the amniocentesis needles market
Key Players:
The key players in the amniocentesis needles market include Medtronic (Ireland), BD (US), CooperSurgical (US), Integra LifeSciences (US), Smiths Medical (US), Medline (US), Cook Medical (US), Laboratoire CCD (France), Biopsybell (Italy), RI.MOS. (Italy), TSUNAMI MEDICAL (Italy), and Rocket Medical (UK).
The key players in the amniocentesis needles market include Medtronic (Ireland), BD (US), CooperSurgical (US), Integra LifeSciences (US), Smiths Medical (US), Medline (US), Cook Medical (US), Laboratoire CCD (France), Biopsybell (Italy), RI.MOS. (Italy), TSUNAMI MEDICAL (Italy), and Rocket Medical (UK).
Comments
Post a Comment